ArticleInternational journal of molecular sciences2022

A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors.

Seri Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.